IDEAYA Biosciences Inc
NASDAQ:IDYA

Watchlist Manager
IDEAYA Biosciences Inc Logo
IDEAYA Biosciences Inc
NASDAQ:IDYA
Watchlist
Price: 29.47 USD -3.35% Market Closed
Market Cap: 2.5B USD
Have any thoughts about
IDEAYA Biosciences Inc?
Write Note

Balance Sheet

Balance Sheet Decomposition
IDEAYA Biosciences Inc

Current Assets 932.2m
Cash & Short-Term Investments 920m
Receivables 20k
Other Current Assets 12.2m
Non-Current Assets 307.7m
Long-Term Investments 280.1m
PP&E 26.6m
Other Non-Current Assets 911k
Current Liabilities 40.7m
Accounts Payable 12.6m
Accrued Liabilities 28.1m
Non-Current Liabilities 18.8m
Other Non-Current Liabilities 18.8m

Balance Sheet
IDEAYA Biosciences Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
6
21
34
72
92
69
157
Cash Equivalents
6
21
34
72
92
69
157
Short-Term Investments
7
70
65
212
155
296
368
Total Receivables
0
0
0
2
1
0
0
Accounts Receivables
0
0
0
2
1
0
0
Other Receivables
0
0
0
0
0
0
0
Other Current Assets
0
1
3
3
3
5
8
Total Current Assets
14
91
102
289
251
371
533
PP&E Net
4
5
10
10
9
9
8
PP&E Gross
4
5
10
10
9
9
8
Accumulated Depreciation
0
1
3
4
6
8
10
Long-Term Investments
0
0
2
0
121
8
107
Other Long-Term Assets
0
1
0
0
0
0
1
Total Assets
18
N/A
97
+451%
113
+17%
298
+164%
381
+28%
388
+2%
649
+67%
Liabilities
Accounts Payable
1
1
1
1
2
4
7
Accrued Liabilities
1
4
6
10
14
19
21
Short-Term Debt
0
0
0
0
0
0
0
Other Current Liabilities
1
0
0
28
29
9
0
Total Current Liabilities
2
5
7
39
45
32
27
Long-Term Debt
3
0
0
0
0
0
0
Other Liabilities
2
2
6
61
35
7
1
Total Liabilities
7
N/A
7
N/A
13
+77%
100
+694%
80
-20%
39
-52%
28
-27%
Equity
Common Stock
26
138
0
0
0
0
0
Retained Earnings
16
51
93
127
177
235
348
Additional Paid In Capital
0
2
193
325
479
588
969
Other Equity
0
0
0
0
1
3
1
Total Equity
10
N/A
89
+768%
100
+12%
198
+98%
302
+52%
350
+16%
621
+78%
Total Liabilities & Equity
18
N/A
97
+451%
113
+17%
298
+164%
381
+28%
388
+2%
649
+67%
Shares Outstanding
Common Shares Outstanding
20
20
20
30
39
48
65

See Also

Discover More